Medicated module with lock feature

Patent metadata

Field	Value
Publication number	US-9463285-B2
Application number	US-201214110540-A
Country	US
Kind code	B2
Filing date	Apr 19, 2012
Priority date	Apr 21, 2011
Publication date	Oct 11, 2016
Grant date	Oct 11, 2016

Abstract

A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module is initially in a locked state until attached to a drug delivery where interaction of the cartridge holder with the module bypass housing changes the module to a triggerable state. The medicated module does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a biasing member automatically activates the reservoir when the needle guard is retracted when the module is in the triggerable state. The needle guard prevents accidental needle sticks before and after an injection, and locks after removal from the injection site.

First claim

The invention claimed is:

1. A medicated module attachable to a drug delivery device, comprising,
a locked state and an unlocked state;
an outer housing having a proximal end, a distal end, and an inner surface, where the proximal end has an upper hub and a connector configured for attachment to a drug delivery device;
a bypass housing comprising an outer surface and a step down edge at a proximal end, wherein the bypass housing is located inside the outer housing and is configured to move both rotationally and axially relative thereto;
a reservoir within the bypass housing comprising a medicament;
a needle guard having inner and outer walls, wherein the inner wall is configured to engage the bypass housing to cause movement of the bypass housing, and wherein the needle guard outer wall is slidably engaged with the inner surface of the outer housing to prevent the needle guard from rotating during linear movement relative to the outer housing; and
a biasing member engaged between the needle guard and a lower hub located at the distal end of the bypass housing, configured to bias the needle guard into an extended or guarded position;
wherein the upper hub has a cutout in a proximal end face of the upper hub that allows functional access to a portion of the proximal end of the bypass housing to allow the medicated module to change state from the locked state to the unlocked state, wherein in the locked state the needle guard cannot rotate the bypass housing such that the distal needle cannula is not fluidly engaged with the secondary medicament in the secondary reservoir, and wherein in the unlocked state axial movement of the needle guard in a proximal direction causes the bypass housing to rotate and the biasing member to be compressed exerting a force on the lower hub and the bypass housing urging them both to move proximally, wherein when the lower hub is moved proximally the distal needle cannula of the lower hub is caused to become fluidly engaged with the secondary medicament in the secondary reservoir.

2. The medicated module of claim 1 , wherein in the locked state the needle guard is axially locked to the bypass housing.

3. The medicated module of claim 1 , wherein in the locked state the bypass housing is in a first position and wherein in the unlocked state the bypass housing is in a second position.

4. The medicated module of claim 3 , wherein the bypass housing is configured to be rotated from the first position to the second position.

5. The medicated module of claim 3 , wherein the bypass housing is configured to be moved axially in a distal direction from the first position to the second position.

6. The medicated module of claim 1 , wherein the inner wall of the needle guard has a radial protrusion and the outer surface of the bypass housing has a nonlinear track configured to engage the radial protrusion to cause rotation and/or axial movement of the bypass housing upon axial movement of the needle guard.

7. The medicated module of claim 6 , wherein the nonlinear track comprises a straight or flat portion and a helical portion, wherein in the locked state the flat portion is engaged with the needle guard protrusion, and in the unlocked state, the helical portion is engaged with the needle guard protrusion.

8. The medicated module of claim 7 , wherein the bypass housing has a rotation tab projecting radially from an inner surface.

9. The medicated module of claim 7 , wherein the bypass housing has a rotation tab projecting axially from the proximal end.

10. The medicated module of claim 6 , wherein the bypass housing has an engagement recess in the proximal end.

11. The medicated module of claim 10 wherein the engagement recess is configured to engage a tab projecting distally from the upper hub to prevent axial movement and rotation of the bypass housing.

12. The medicated module of claim 1 wherein the lower hub holds a double-ended needle cannula, wherein when the needle guard is in the guarded position the double ended needle cannula of the lower hub is covered by the needle guard.

13. The medicated module of claim 1 , wherein the upper hub further comprises a proximal needle cannula, wherein in the unlocked state, when the bypass housing is moved proximally, the medicament in the reservoir is caused to become engaged with the proximal needle cannula.

14. The medicated module of claim 1 , wherein the reservoir is a single molded component having an internal cavity with an integral flow distributor.

15. The medicated module of claim 1 further comprising a fluid flow path that bypasses the reservoir.

16. The medicated module of claim 15 , wherein the fluid flow path that bypasses the reservoir comprises a channel on the outside of the reservoir.

17. The medicated module of claim 15 , wherein the fluid flow path that bypasses the reservoir comprises a channel on the bypass housing, e.g. on the inner surface of the bypass housing.

18. The medicated module of claim 1 wherein the medicament comprises a liquid medicament.

19. The medicated module of claim 1 wherein the medicament comprises one of a GLP-1 or a premix of insulin and a GLP-1.

20. The medicated module of claim 1 , wherein prior to attachment to a drug delivery device the medicated module is in the locked state such that it is not possible to inject the contents, and wherein after attachment to a drug delivery device, the medicated module is in an unlocked state such that medicament from the attached drug delivery device can be dispensed and upon retraction of the guard a combined dose of medicaments from the drug delivery device and the reservoir can be dispensed.

21. The medicated module of claim 1 , wherein in the locked state the bypass housing is rotationally locked to the upper hub.

22. A drug delivery device attachable to a medicated module according to claim 1 , wherein the drug delivery device comprises a reservoir of medicament containing at least one drug agent and a dose button operably connected to the reservoir, and further comprises axially or radially projecting tabs configured to functionally access a portion of the proximal end of the bypass housing allowing the medicated module to change state from locked to unlocked.

23. A drug delivery device according to claim 22 , wherein the tabs are configured to cause the bypass housing to be moved from the first position to the second position.

24. A drug delivery device according to claim 22 , wherein the tabs are arranged to cause the bypass housing to be rotated from the first position to the second position, when the medicated module is attached to the drug delivery device.

25. A drug delivery device according to claim 22 , wherein the tabs are arranged to cause the bypass housing to be moved axially from the first position to the second position in distal direction, when the medicated module is attached to the drug delivery device.

26. A drug delivery system to deliver two or more medicaments operable through a single dispense interface, comprising,
a primary reservoir of medicament containing at least one drug agent;
a dose button operably connected to the primary reservoir of medicament;
a single dispense interface configured for fluid communication with the primary reservoir; and
the medicated module of claim 1 .

Assignees

• Mercer David Richard
• Kouyoumjian Garen
• Boyd Malcolm Stanley
• Bainton Michael
• Cross John David
• Sanofi Aventis Deutschland

Inventors

• Mercer David Richard
• Kouyoumjian Garen
• Boyd Malcolm Stanley
• Bainton Michael
• Cross John David

Classifications

• A61M5/347

  rotatable, e.g. bayonet or screw (A61M5/344 takes precedence) · CPC title

• A61M2205/582

  by tactile feedback · CPC title

• A61M5/31533

  Dosing mechanisms, i.e. setting a dose (administrating mechanisms A61M5/31565) · CPC title

• A61M5/3146

  Priming, e.g. purging, reducing backlash or clearance · CPC title

• A61M2205/581

  by audible feedback · CPC title